Skip to content
Open access · CC-BY via OpenAlex

Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome

Ashley S. Williams, Timothy R. Koves, Yasminye D. Pettway, James A. Draper, Dorothy H. Slentz, Paul A. Grimsrud, Olga Ilkayeva, Deborah M. Muoio

iScience · 2021 · ▲ 17 citations

Abstract

Nicotinamide riboside supplements (NRS) have been touted as a nutraceutical that promotes cardiometabolic and musculoskeletal health by enhancing nicotinamide adenine dinucleotide (NAD + ) biosynthesis, mitochondrial function, and/or the activities of NAD-dependent sirtuin deacetylase enzymes. This investigation examined the impact of NRS on whole body energy homeostasis, skeletal muscle mitochondrial function, and corresponding shifts in the acetyl-lysine proteome, in the context of diet-induced obesity using C57BL/6NJ mice. The study also included a genetically modified mouse model that imposes greater demand on sirtuin flux and associated NAD + consumption, specifically within muscle tissues. In general, whole body glucose control was marginally improved by NRS when administered at the midpoint of a chronic high-fat diet, but not when given as a preventative therapy upon initiation of the diet. Contrary to anticipated outcomes, the study produced little evidence that NRS increases tissue NAD + levels, augments mitochondrial function, and/or mitigates diet-induced hyperacetylation of the skeletal muscle proteome.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.isci.2021.103635
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Williams, A.S., Koves, T.R., Pettway, Y.D., Draper, J.A., Slentz, D.H., Grimsrud, P.A., Ilkayeva, O., &amp; Muoio, D.M. (2021). Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome. <em>iScience</em>. https://doi.org/10.1016/j.isci.2021.103635
Vancouver
Williams AS, Koves TR, Pettway YD, Draper JA, Slentz DH, Grimsrud PA, et al. Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome. iScience. 2021. doi:10.1016/j.isci.2021.103635.
BibTeX
@article{ashley2021Nicoti, title = {Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome}, author = {Ashley S. Williams and Timothy R. Koves and Yasminye D. Pettway and James A. Draper and Dorothy H. Slentz and Paul A. Grimsrud and Olga Ilkayeva and Deborah M. Muoio}, journal = {iScience}, year = {2021}, doi = {10.1016/j.isci.2021.103635}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings